Explore News
-
Big Three Insulin Makers Control 90% of Market
The dominance of three pharmaceutical companies over the global insulin market has severe consequences.
-
Hospitals to Reduce Wait Times by 30% with New Tool
Concordia University’s innovative solution to streamline hospital operations
-
AI Model Breaks Ground in Diffuse Optical Tomography
Revolutionary AI technology paves the way for rapid diagnosis of hemorrhages and tumors
-
Why Insulin Remains a Luxury for Many Diabetics
Diabetes patients struggle to access lifesaving insulin due to high costs and supply chain issues
-
Why a £28m Payout Won’t Fix the NHS’s Maternity Care Issues
A mother’s fight for justice after her daughter’s birth tragedy
-
Why Empathy Matters in Healthcare
Research reveals a significant link between empathy and patient care quality
-
Why Cancer Researchers Are Optimistic About New Treatments
New cancer treatments show promising results at annual research summit
-
Medicaid Work Requirements to Impact 8 Million
Stricter rules may lead to loss of coverage for people with serious illnesses
-
Why Digital Platforms Matter for GLP-1 Access
New models of pharmaceutical access are emerging in the US
-
Why cancer treatment is on the cusp of a breakthrough
Breakthrough trial brings new hope for cancer patients
